Perspectives of Nanotechnology in Minimally Invasive Therapy of Breast Cancer

Yang, Yamin; Wang, Hongjun

doi:https://doi.org/10.1260/2040-2295.4.1.67

Journal of Healthcare Engineering

On this page

Abstract References Copyright Related Articles

Research Article | Open Access

Volume 4 | Article ID 829834 | https://doi.org/10.1260/2040-2295.4.1.67

Perspectives of Nanotechnology in Minimally Invasive Therapy of Breast Cancer

Yamin Yang¹and Hongjun Wang¹

Received01 Sept 2012

Accepted01 Nov 2012

Abstract

Breast cancer, the most common type of cancer among women in the western world, affects approximately one out of every eight women over their lifetime. In recognition of the high invasiveness of surgical excision and severe side effects of chemical and radiation therapies, increasing efforts are made to seek minimally invasive modalities with fewer side effects. Nanoparticles (<100 nm in size) have shown promising capabilities for delivering targeted therapeutic drugs to cancer cells and confining the treatment mainly within tumors. Additionally, some nanoparticles exhibit distinct properties, such as conversion of photonic energy into heat, and these properties enable eradication of cancer cells. In this review, current utilization of nanostructures for cancer therapy, especially in minimally invasive therapy, is summarized with a particular interest in breast cancer.

References

What are the key statistics about breast cancer?, http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics, Accessed December 05, 2012.
H. M. Heneghan, R. S. Prichard, A. Devaney et al., “Evolution of breast cancer management in Ireland: a decade of change,” BMC surgery, vol. 9:15, 2009.
View at: Google Scholar
P. D. Loprinzi and B. J. Cardinal, “Effects of physical activity on common side effects of breast cancer treatment,” Breast cancer, vol. 19, pp. 4–10, 2012.
View at: Google Scholar
M. Noguchi, “Minimally invasive surgery for small breast cancer,” Journal of surgical oncology, vol. 84, pp. 94–101, 2003.
View at: Google Scholar
S. E. V. A. Singletary, “Minimally invasive techniques in breast,” Seminars in Surgical Oncology, vol. 20, no. 3, pp. 246–250, 2001.
View at: Google Scholar
W. K. Hung, M. Ying, C. M. Chan, H. S. Lam, and K. L. Mak, “Minimally invasive technology in the management of breast disease,” Breast cancer, vol. 16, pp. 23–29, 2009.
View at: Google Scholar
I. Brigger, C. Dubernet, and P. Couvreur, “Nanoparticles in cancer therapy and diagnosis,” Advanced drug delivery reviews, vol. 54, pp. 631–651, 2012.
View at: Google Scholar
Y.--E. Choi, J.-W. Kwak, and J. W. Park, “Nanotechnology for early cancer detection,” Sensors, vol. 10, pp. 428–455, 2010.
View at: Google Scholar
J. Conde, G. Doria, and P. Baptista, “Noble metal nanoparticles applications in cancer,” Journal of drug delivery, 2012, 751075.
View at: Google Scholar
L. Brannon-Peppas and J. O. Blanchette, “Nanoparticle and targeted systems for cancer therapy,” Advanced drug delivery reviews, vol. 56, pp. 1649–1659, 2004.
View at: Google Scholar
O. M. Koo, I. Rubinstein, and H. Onyuksel, “Role of nanotechnology in targeted drug delivery and imaging: a concise review,” NanoMedicine: nanotechnology, biology, and medicine, vol. 1, pp. 193–212, 2005.
View at: Google Scholar
R. Sinha, G. J. Kim, S. Nie, and D. M. Shin, “Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery,” Molecular cancer therapeutics, vol. 5, pp. 1909–1917, 2006.
View at: Google Scholar
K. Kim, J. H. Kim, H. Park et al., “Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring,” Journal of controlled release, vol. 146, pp. 219–227, 2010.
View at: Google Scholar
M. Wang and M. Thanou, “Targeting nanoparticles to cancer,” Pharmacological research: the official journal of the Italian Pharmacological Society, vol. 62, pp. 90–99, 2010.
View at: Google Scholar
M. K. Yu, J. Park, Y. Y. Jeong, W. K. Moon, and S. Jon, “Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery,” Nanotechnology, vol. 21:415102, 2010.
View at: Google Scholar
V. P. Torchilin, “Polymer-coated long-circulating microparticulate pharmaceuticals,” Journal of microencapsulation, vol. 15, pp. 1–19, 1998.
View at: Google Scholar
A. Moore, E. Marecos, A. Bogdanov, and R. Weissleder, “Tumoral distribution of iron oxide nanoparticles in a rodent model 1,” Radiology, vol. 214, 2000.
View at: Google Scholar
S. M. Moghimi, a. C. Hunter, and J. C. Murray, “Long-circulating and target-specific nanoparticles: theory to practice,” Pharmacological reviews, vol. 53, pp. 283–318, 2001.
View at: Google Scholar
P. Senthil Kumar, I. Pastoriza-Santos, B. Rodríguez-González, F. Javier García de Abajo, and L. M. Liz-Marzán, “High-yield synthesis and optical response of gold nanostars,” Nanotechnology, vol. 19:015606, 2008.
View at: Google Scholar
L. Principe, S. D'Arezzo, A. Capone, N. Petrosillo, and P. Visca, “In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii,” Annals of clinical microbiology and antimicrobials, vol. 8:18, 2009.
View at: Google Scholar
T. L. Doane and C. Burda, “The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy,” Chemical Society reviews, vol. 41, pp. 2885–2911, 2012.
View at: Google Scholar
C. L. Waite and C. M. Roth, “Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities,” Critical reviews in biomedical engineering, vol. 40, pp. 21–41, 2012.
View at: Google Scholar
R. Ranganathan, S. Madanmohan, A. Kesavan et al., “Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications,” International journal of nanomedicine, vol. 7, pp. 1043–1060, 2012.
View at: Google Scholar
C. Heneweer, S. E. M. Gendy, and O. Peñate-Medina, “Liposomes and inorganic nanoparticles for drug delivery and cancer imaging,” .Therapeutic delivery, vol. 3, pp. 645–656, 2012.
View at: Google Scholar
P. Kumar, A. Gulbake, and S. K. Jain, “Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy,” Critical reviews in therapeutic drug carrier Systems, vol. 29, pp. 355–419, 2012.
View at: Google Scholar
Y. Namiki, T. Fuchigami, N. Tada et al., “Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring,” Accounts of chemical research, vol. 44, pp. 1080–1093, 2011.
View at: Google Scholar
C.-M. J. Hu and L. Zhang, “Nanoparticle-based combination therapy toward overcoming drug resistance in cancer,” Biochemical pharmacology, vol. 83, pp. 1104–1111, 2012.
View at: Google Scholar
L. M. Kaminskas, V. M. McLeod, C. J. H. Porter, and B. J. Boyd, “Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation,” Molecular pharmaceutics, vol. 9, pp. 355–373, 2012.
View at: Google Scholar
M. Wankhede, A. Bouras, M. Kaluzova, and C. G. Hadjipanayis, “Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy,” Expert review of clinical pharmacology, vol. 5, pp. 173–186, 2012.
View at: Google Scholar
L. Tong, M. Zhao, S. Zhu, and J. Chen, “Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer,” Frontiers of medicine, vol. 5, pp. 379–387, 2011.
View at: Google Scholar
L. Dykman and N. Khlebtsov, “Gold nanoparticles in biomedical applications: recent advances and perspectives,” Chemical Society reviews, vol. 41, pp. 2256–2282, 2012.
View at: Google Scholar
P. Cherukuri and S. A. Curley, “Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells,” Methods in molecular biology, vol. 624, pp. 359–373, 2010.
View at: Google Scholar
S. Abbasi, A. Paul, W. Shao, and S. Prakash, “Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment,” Journal of drug delivery, 2012, 686108.
View at: Google Scholar
Lee S.-M., T. V. O'Halloran, and S. T. Nguyen, “Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy,” Journal of the American Chemical Society, vol. 132, pp. 17130–17138, 2010.
View at: Google Scholar
F. Danhier, N. Lecouturier, B. Vroman et al., “Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation,” Journal of controlled release: official journal of the Controlled Release Society, vol. 133, pp. 11–17, 2009.
View at: Google Scholar
C. Yang, H. Z. Liu, Z. X. Fu, and W. D. Lu :, “Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma,” BMC biotechnology, vol. 11:21, 2011.
View at: Google Scholar
P. Agrawal, G. J. Strijkers, and K. Nicolay, “Chitosan-based systems for molecular imaging,” Advanced drug delivery reviews, vol. 62, pp. 42–58, 2010.
View at: Google Scholar
R. M. Taylor and L. O. Sillerud, “Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner,” International journal of nanomedicine, vol. 7, pp. 4341–4352, 2012.
View at: Google Scholar
L. Xu, K. F. Pirollo, W. H. Tang, A. Rait, and E. H. Chang, “Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts,” Human gene therapy, vol. 10, pp. 2941–2952, 1999.
View at: Google Scholar
Y. Wu, W. Wang, Y. Chen et al., “The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro,” International journal of nanomedicine, vol. 5, pp. 129–136, 2010.
View at: Google Scholar
T. R. Daniels, E. Bernabeu, J. A. Rodríguez et al., “The transferrin receptor and the targeted delivery of therapeutic agents against cancer,” Biochimica et biophysica acta, vol. 1820, pp. 291–317, 2012.
View at: Google Scholar
R. S. T. Aydin, “Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting,” Journal of biomedical materials research. Part A, 2012.
View at: Google Scholar
Y. Mi, X. Liu, J. Zhao, J. Ding, and S.-S. Feng, “Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers,” Biomaterials, vol. 33, pp. 7519–7529, 2012.
View at: Google Scholar
P. Zhao, H. Wang, M. Yu et al., “Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation,” European journal of pharmaceutics and biopharmaceutics, vol. 81, pp. 248–256, 2012.
View at: Google Scholar
B. D. Fornage and B. S. Edeiken, “Percutaneous ablation of breast tumors,” Tumor ablation, vol. 5, pp. 428–439, 2005.
View at: Google Scholar
M. Salagierski and M. S. Salagierski, “Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management,” Cancers, vol. 2, pp. 1895–1900, 2010.
View at: Google Scholar
R. W. Y. Habash, R. Bansal, D. Krewski, and T. Hafi, “Thermal therapy, Part III: ablation,” vol. 35, pp. 37–121, 2007.
View at: Google Scholar
J. Cardinal, J. R. Klune, E. Chory et al., “Non-invasive radiofrequency ablation of cancer targeted by gold nanoparticles,” Surgery, vol. 144, pp. 125–132, 2008.
View at: Google Scholar
C. J. Gannon, C. R. Patra, R. Bhattacharya, P. Mukherjee, and S. Curley, “Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells,” Journal of nanobiotechnology, vol. 6:2, 2008.
View at: Google Scholar
V. H. B. Ho, M. J. Smith, and N. K. H. Slater, “Effect of magnetite nanoparticle agglomerates on the destruction of tumor spheroids using high intensity focused ultrasound.,” Ultrasound in medicine & biology, vol. 37, pp. 169–175, 2011.
View at: Google Scholar
Y. Sun, Y. Zheng, H. Ran et al., “Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation,” Biomaterials, vol. 33, pp. 5854–5864, 2012.
View at: Google Scholar
J.-F. Yan and J. Liu, “Nanocryosurgery and its mechanisms for enhancing freezing efficiency of tumor tissues,” NanoMedicine: nanotechnology, biology, and medicine, vol. 4, pp. 79–87, 2008.
View at: Google Scholar
R. Goel, D. Swanlund, J. Coad, G. F. Paciotti, and J. C. Bischof, “TNF-alpha-based accentuation in cryoinjury—dose, delivery, and response,” Molecular cancer therapeutics, vol. 6, pp. 2039–2047, 2007.
View at: Google Scholar
Y. N. Konan, M. Berton, R. Gurny, and E. Allémann, “Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles,” European journal of pharmaceutical sciences, vol. 18, pp. 241–249, 2003.
View at: Google Scholar
E. Ricci-Júnior and J. M. Marchetti, “Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use,” International journal of pharmaceutics, vol. 310, pp. 187–195, 2006.
View at: Google Scholar
I. Roy, T. Y. Ohulchanskyy, H. E. Pudavar et al., “Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy,” Journal of the American Chemical Society, vol. 125, pp. 7860–7865, 2003.
View at: Google Scholar
M. E. Wieder, D. C. Hone, M. J. Cook, M. M. Handsley, J. Gavrilovic, and D. Russell, “Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a “Trojan horse”,” Photochemical & photobiological sciences, vol. 5, pp. 727–734, 2006.
View at: Google Scholar
M. Kyaw, K. Oo, X. Yang, H. Du, and H. Wang, “5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer,” Nanomedicine, vol. 3, no. 6, pp. 777–786, 2008.
View at: Google Scholar
M. K. Khaing Oo, Y. Yang, Y. Hu, M. Gomez, H. Du, and H. Wang, “Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX,” ACS nano, vol. 6, pp. 1939–1947, 2012.
View at: Google Scholar
I. H. El-Sayed, X. Huang, and M. El-Sayed, “Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles,” Cancer letters, vol. 239, pp. 129–135, 2006.
View at: Google Scholar
X. Huang, P. K. Jain, I. H. El-Sayed, and M. El-Sayed, “Plasmonic photothermal therapy (PPTT) using gold nanoparticles,” Lasers in medical science, vol. 23, pp. 217–28, 2008.
View at: Google Scholar
L. B. Carpin, L. R. Bickford, G. Agollah et al., “Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells,” Breast cancer research and treatment, vol. 125, pp. 27–34, 2011.
View at: Google Scholar
G. von Maltzahn, J.-H. Park, A. Agrawal et al., “Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas,” Cancer research, vol. 69, pp. 3892–3900, 2009.
View at: Google Scholar
F. Zhou, D. Xing, Z. Ou, B. Wu, D. E. Resasco, and W. R. Chen, “Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes,” Journal of biomedical optics, vol. 14: 021009, 2009.
View at: Google Scholar
G. Vlastos and H. M. Verkooijen, “Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer,” The oncologist, vol. 12, pp. 1–10, 2007.
View at: Google Scholar
A. N. Mirza, B. D. Fornage, N. Sneige et al., “Radiofrequency ablation of solid tumors,” Cancer journal, vol. 7, pp. 95–102, 2001.
View at: Google Scholar
F. Izzo, R. Thomas, P. Delrio et al., “Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients,” Cancer, vol. 92, pp. 2036–44, 2001.
View at: Google Scholar
Z.-Z. J. Lim, J.-E. J. Li , C.-T. Ng , L.-Y. L. Yung, and B.-H. Bay, “Gold nanoparticles in cancer therapy,” Acta pharmacologica Sinica, vol. 32, pp. 983–990, 2011.
View at: Google Scholar
S. Jain, D. G. Hirst, and J. M. O'Sullivan, “Gold nanoparticles as novel agents for cancer therapy,” The British journal of radiology, vol. 85, pp. 101–113, 2012.
View at: Google Scholar
X. Huang, P. K. Jain, I. H. El-Sayed, and M. A. El-Sayed, “Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy,” Nanomedicine, vol. 2, pp. 681–693, 2007.
View at: Google Scholar
R. A. Rippel and A. M. Seifalian, “Gold revolution-gold nanoparticles for modern medicine and surgery,” Journal of nanoscience and nanotechnology, vol. 11, pp. 3740–3748, 2011.
View at: Google Scholar
S. Lee, H. Chon, M. Lee et al., “Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres,” Biosensors & bioelectronics, vol. 24, pp. 2260–2263, 2009.
View at: Google Scholar
N. Chattopadhyay, Z. Cai, J. Pignol et al., “Design and characterization of her-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer,” Mol. Pharmaceutics, vol. 7, no. 6, pp. 2194–2206, 2010.
View at: Google Scholar
L. Chen, D. Bouley, E. Yuh, H. D'Arceuil, and K. Butts, “Study of focused ultrasound tissue damage using MRI and histology,” Journal of magnetic resonance imaging, vol. 10, pp. 146–153, 1999.
View at: Google Scholar
McDannold, K. Hynynen, D. Wolf, G. Wolf, and F. Jolesz, “MRI evaluation of thermal ablation of tumors with focused ultrasound,” Journal of magnetic resonance imaging, vol. 8, pp. 91–100, 1998.
View at: Google Scholar
H. E. Cline, K. Hynynen, R. D. Watkins et al., “Focused US system for MR imaging-guided tumor ablation,” Radiology, vol. 194, pp. 731–737, 1995.
View at: Google Scholar
D. Gianfelice, A. Khiat, M. Amara, and A. Belblidia, “Radiology MR imaging-guided focused us ablation of breast cancer: histopathologic assessment of effectiveness- initial,” Radiology, vol. 227, no. 3, pp. 849–855, 2002.
View at: Google Scholar
J. E. Kennedy, “High-intensity focused ultrasound in the treatment of solid tumours. Nature reviews,” Cancer, vol. 5, pp. 321–327, 2005.
View at: Google Scholar
Y.-Y. Li, W.-H. Sha, Y.-J. Zhou, and Y.-Q. Nie, “Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma,” Journal of gastroenterology and hepatology, vol. 22, pp. 2148–2154, 2007.
View at: Google Scholar
S.-Y. Choi, Y.-S. Kim, Y.-J. Seo, J. Yang, and K.-S. Choi, “Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation,” PloS One, vol. 7:e34333, 2012.
View at: Google Scholar
D. Theodorescu, “Cancer cryotherapy: evolution and biology,” Rev Urol, vol. 6, Suppl 4, pp. S9–S19, 2004.
View at: Google Scholar
R. Goel, K. Anderson, J. Slaton et al., “Adjuvant approaches to enhance cryosurgery,” Journal of biomechanical engineering, vol. 131:074003, 2009.
View at: Google Scholar
M. S. Sabel, C. S. Kaufman, P. Whitworth et al., “Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial,” Annals of surgical oncology, vol. 11, pp. 542–549, 2004.
View at: Google Scholar
J. Liu and Z.-S. Deng, “Nano-cryosurgery: advances and challenges,” Journal of Nanoscience and Nanotechnology, vol. 9, pp. 4521–4542, 2009.
View at: Google Scholar
D. C. Shackley, C. Whitehurst, J. V. Moore, and C. Betts, “Photodynamic therapy,” Journal of the royal society of medicine, vol. 92, no. 11, pp. 562–565, 1999.
View at: Google Scholar
V. Santosa and L. Limantara, “Review photodynamic therapy: new light in medicine worlD,” Indo. J. Chem, vol. 8, pp. 279–291, 2008.
View at: Google Scholar
J.-H. Yoon, H.-E. Yoon, O. Kim, S. K. Kim, S.-G. Ahn, and K. W. Kang, “The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells,” Lasers in surgery and medicine, vol. 44, pp. 76–86, 2012.
View at: Google Scholar
A.-R. Montazerabadi, A. Sazgarnia, M. H. Bahreyni-Toosi, A. Ahmadi, A. Shakeri-Zadeh, and A. Aledavood, “Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer,” Photodiagnosis and photodynamic therapy, vol. 9, pp. 46–51, 2012.
View at: Google Scholar
T.-G. Ahn, B.-R. Lee, E.-Y. Choi, D. W. Kim, and S.-J. Han, “Photodynamic therapy for breast cancer in a BALB/c mouse model,” Journal of gynecologic oncology, vol. 23, pp. 115–119, 2012.
View at: Google Scholar
D. K. Chatterjee, L. S. Fong, and Y. Zhang, “Nanoparticles in photodynamic therapy: an emerging paradigm,” Advanced drug delivery reviews, vol. 60, pp. 1627–1637, 2008.
View at: Google Scholar
J. Qian, D. Wang, F. Cai, Q. Zhan, Y. Wang, and S. He, “Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging,” Biomaterials, vol. 33, pp. 4851–4860, 2012.
View at: Google Scholar
X. Jia and L. Jia, “Nanoparticles improve biological functions of phthalocyanine photosensitizers used for photodynamic therapy,” Current drug metabolism, 2012.
View at: Google Scholar
S. Battah, S. Balaratnam, A. Casas et al., “.Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates,” Molecular cancer therapeutics, vol. 6, pp. 876–85, 2007.
View at: Google Scholar
P. Huang, J. Lin, D. Yang, C. Zhang, Z. Li, and D. Cui, “Photosensitizer-loaded dendrimer-modified multi-walled carbon nanotubes for photodynamic therapy,” Journal of controlled release, vol. 152, Suppl, pp. e33–4, 2011.
View at: Google Scholar
T. Stuchinskaya, M. Moreno, M. J. Cook, D. R. Edwards, and D. A. Russell, “Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates,” Photochemical & photobiological sciences, vol. 10, pp. 822–831, 2011.
View at: Google Scholar
N. Kameyama, S. Matsuda, O. Itano et al., “Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study,” Cancer biotherapy & radiopharmaceuticals, vol. 26, pp. 697–704, 2011.
View at: Google Scholar
B. Jang, J. Park, C. Tung, I. Kim, and Y. Choi, “Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo,” ACS Nano, vol. 5, no. 2, pp. 1086–1094, 2011.
View at: Google Scholar
B. Jang and Y. Choi, “Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy,” Theranostics, vol. 2, pp. 190–197, 2012.
View at: Google Scholar
W.--S. Kuo , C.-N. Chang, Y.-T. Chang et al., “Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging,” Angewandte Chemie, vol. 49, pp. 2711–2715, 2010.
View at: Google Scholar
J. C. Y. Kah, R. C. Y. Wan, K. Y. Wong, S. Mhaisalkar, C. J. R. Sheppard, and M. Olivo, “Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: an in vitro study,” Lasers in surgery and medicine, vol. 40, pp. 584–589, 2008.
View at: Google Scholar
E. S. Day, P. Thompson, L. Zhang et al., “Nanoshell-mediated photothermal therapy improves survival in a murine glioma model,” Journal of neuro-oncology, vol. 104, pp. 55–63, 2011.
View at: Google Scholar
J. K. Young, E. R. Figueroa, and R. Drezek, “Tunable nanostructures as photothermal theranostic agents,” Annals of biomedical engineering, vol. 40, pp. 438–459, 2012.
View at: Google Scholar
R. J. Bernardi, A. R. Lowery, P. A. Thompson, S. M. Blaney, and J. L. West, “Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines,” Journal of neuro-oncology, vol. 86, pp. 165–172, 2008.
View at: Google Scholar
A. M. Gobin, M. H. Lee, N. J. Halas, W. D. James, R. A. Drezek, and J. L. West, “Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy,” Nano letters, vol. 7, pp. 1929–1934, 2007.
View at: Google Scholar
A. M. Gobin, E. M. Watkins, E. Quevedo, V. L. Colvin, and L. West, “Near infrared resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent,” Small, no. 6, pp. 745–752, 2011.
View at: Google Scholar
K. C. Black, J. Yi, J. G. Rivera, D. C. Zelasko-Leon, and P. B. Messersmith, “Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy,” Nanomedicine, 2012.
View at: Google Scholar
C. Hong, “Photothermal therapy using TiO₂ nanotubes in combination with near-infrared laser,” Journal of Cancer Therapy, vol. 01, pp. 52–58, 2010.
View at: Google Scholar
X. Wang, C. Wang, L. Cheng, S.-T. Lee, and Z. Liu, “Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy,” Journal of the American Chemical Society, vol. 134, pp. 7414–7422, 2012.
View at: Google Scholar
F. Liang and B. Chen, “A review on biomedical applications of single-walled carbon nanotubes,” Current medicinal chemistry, vol. 17, pp. 10–24, 2010.
View at: Google Scholar
A. V. Liopo, M. P. Stewart, J. Hudson, J. M. Tour, and T. C. Pappas, “Biocompatibility of native and functionalized single-walled carbon nanotubes for neuronal interface,” Journal of nanoscience and nanotechnology, vol. 6, pp. 1365–1374, 2006.
View at: Google Scholar
G. von Maltzahn, J.-H. Park, A. Agrawal et al., “Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas,” Cancer research, vol. 69, pp. 3892–3900, 2009.
View at: Google Scholar
W. Cai, “Applications of gold nanoparticles in cancer nanotechnology,” Nanotechnology, Science and Applications, vol. 1, pp. 17–32, 2008.
View at: Google Scholar
A. Albanese, P. S. Tang, and W. C. W. Chan, “The effect of nanoparticle size, shape, and surface chemistry on biological systems,” Annual review of biomedical engineering, vol. 14, pp. 1–16, 2012.
View at: Google Scholar
M. M. Shenoi, N. B. Shah, R. J. Griffin, G. M. Vercellotti, and J. C. Bischof, “Nanoparticle pre-conditioning for enhanced thermal therapies in cancer,” Nanomedicine, vol. 6, pp. 545–563, 2011.
View at: Google Scholar
C. Buzea, I. I. Pacheco, and K. Robbie, “Nanomaterials and nanoparticles: sources and toxicity,” Biointerphases, vol. 2, pp. MR17–71, 2007.
View at: Google Scholar
R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde, and M. Sastry, “Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview,” Langmuir, vol. 21, pp. 10644–10654, 2005.
View at: Google Scholar
Y. Pan, S. Neuss, A. Leifert et al., “Size-dependent cytotoxicity of gold nanoparticles,” Small, vol. 3, pp. 1941–1949, 2007.
View at: Google Scholar
X.-D. Zhang, H.-Y. Wu , D. Wu et al., “Toxicologic effects of gold nanoparticles in vivo by different administration routes,” International journal of nanomedicine, vol. 5, pp. 771–781, 2010.
View at: Google Scholar

Copyright

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

1321

Downloads

1249

Citations